terconazole has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HS; Kyung, SY; Lee, JS; Oh, Y; Park, JH; Yoon, S | 1 |
| KOHLER, L; NIEPER, HA | 1 |
| NIEPER, HA; XALABARDER, C | 1 |
3 other study(ies) available for terconazole and Neoplasms
| Article | Year |
|---|---|
Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.
Topics: Antifungal Agents; Antimitotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Neoplasms; Vincristine | 2022 |
[The development and evaluation of fungistatic compounds in the treatment of cancer. 2].
Topics: Antifungal Agents; Antineoplastic Agents; Humans; Neoplasms; Neoplasms, Experimental; Triazoles | 1963 |
[The development and evaluation of fungistatic compounds in the treatment of cancer. I].
Topics: Antifungal Agents; Antineoplastic Agents; Humans; Neoplasms; Triazoles | 1962 |